Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Dig Liver Dis ; 41(1): 72-7, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18294938

RESUMO

Preoperative systemic chemotherapy is generally applied in patients who undergo hepatic resection for colorectal metastases. Although the tumour response rate has been improved recently with the development of new molecular targeted therapies the related hepatic injury is ill defined. Bevacizumab is a monoclonal antibody to vascular endothelial growth factor. It can achieve high response rates and is accepted as a first line treatment in the metastatic colorectal disease. However, the data about its hepatotoxicity profile is still limited. We describe a case of secondary sclerosing cholangitis in a patient with liver metastases treated by Bevacizumab in the neoadjuvant setting and liver resection. It is possible that Bevacizumab may have induced a hypercoagulative condition that was further precipitated by surgery.


Assuntos
Adenocarcinoma/secundário , Inibidores da Angiogênese/efeitos adversos , Anticorpos Monoclonais/efeitos adversos , Colangite Esclerosante/induzido quimicamente , Neoplasias Hepáticas/secundário , Neoplasias do Colo Sigmoide/patologia , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/cirurgia , Idoso , Alanina Transaminase/sangue , Inibidores da Angiogênese/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Humanizados , Aspartato Aminotransferases/sangue , Bevacizumab , Colangiopancreatografia Retrógrada Endoscópica , Colangiopancreatografia por Ressonância Magnética , Colangite Esclerosante/diagnóstico , Hepatectomia/efeitos adversos , Humanos , Fígado/patologia , Fígado/cirurgia , Testes de Função Hepática , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/cirurgia , Masculino , Terapia Neoadjuvante/efeitos adversos , Neoplasias do Colo Sigmoide/tratamento farmacológico , Tomografia Computadorizada por Raios X , Ultrassonografia
2.
World J Gastroenterol ; 13(6): 826-9, 2007 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-17352009

RESUMO

Liver resections are demanding operations which can have life threatening complications although they are performed by experienced liver surgeons. Recently new technologies are applied in the field of liver surgery, having one goal: safer and easier liver operations. The aim of this article is to address the issue of bloodless liver resection using radiofrequency energy. Radionics, Cool-tip System and Tissue Link are some of the devices which are using radiofrequency energy. All information included in this article, refers to these devices in which we have personal experience in our unit of liver surgery. These devices take advantage of its unique combination of radiofrequency current and internal electrode cooling to perform sealing of the small vessels and biliary radicals. Dissection is also feasible with the cool-tip probe. For the purposes of this study patient sex, age, type of disease and type of surgical procedure in association with the duration of parenchymal transection, blood loss, length of hospital stay, morbidity and mortality were analyzed. Cool-tip RF device may provide a unique, simple and rather safe method of bloodless liver resections if used properly. It is indicated mostly in cirrhotic patients with challenging hepatectomies (segment VIII, central resections). The total operative time is eliminated and the average blood loss is significantly decreased. It is important to note that this technique should not be applied near the hilum or the vena cava to avoid damage of these structures.


Assuntos
Ablação por Cateter/métodos , Hepatectomia/métodos , Fígado/cirurgia , Coagulação Sanguínea/fisiologia , Humanos , Fígado/fisiopatologia , Cirrose Hepática/cirurgia , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Equipamentos Cirúrgicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA